Clinical Trials Sponsored by NITROX, LLC

Total 10807 results

NITROX, LLC

Withdrawn

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

Pulmonary Hypertension

United States
Nitric Oxide Innovations LLC

Terminated

The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin

COVID-19

United States
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in Italy

Viral Conjunctivitis

Italy
NicOx

Completed

Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee

Osteoarthritis

United States
NicOx

Completed

To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension (HCT3012-X-112)

Hypertension | Osteoarthritis

United States
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in Germany

Viral Conjunctivitis

Germany
NicOx

Completed

A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure (HCT3012-X-111)

Hypertension | Osteoarthritis

United States
NicOx

Completed

A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects

Liver Disease

United States
NicOx

Completed

Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip

Osteoarthritis | Osteoarthritis, Hip

United States, Canada
NicOx

Completed

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function (HCT3012-X-106)

Renal Failure

United States
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in Spain

Viral Conjunctivitis

Spain
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in UK

Viral Conjunctivitis

United Kingdom
NicOx

Completed

ADenoVirus Initiative Study in Epidemiology in France

Viral Conjunctivitis

France
NicOx

Completed

Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male

Pharmacokinetics
NicOx

Completed

Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide

Renal Hemodynamics
NicOx

Completed

Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee

Osteoarthritis
Intron Biotechnology, Inc.

Terminated

Phase IIa Clinical Study of N-Rephasin® SAL200

Anti-Bacterial Agents | Staphylococcus Aureus Bacteremia

Korea, Republic of
Intron Biotechnology, Inc.

Completed

A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011

Acute Radiation Syndrome

Korea, Republic of
Nitric Solutions Inc.

Completed

Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot

Tinea Pedis

Canada
Nitric BioTherapeutics, Inc

Completed

Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis

Onychomycosis

United States, Canada
Nitric BioTherapeutics, Inc

Terminated

Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers

Venous Ulcers

United States
Nitric BioTherapeutics, Inc

Terminated

Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)

Skin Ulcers | Methicillin-resistant Staphylococcus Aureus Infection

United Kingdom
Nitric BioTherapeutics, Inc

Completed

Efficacy Study to Evaluate the Effect of Nitric Oxide on the Treatment of Tinea Pedis (Athlete's Foot)

Tinea

Canada
Intron Biotechnology, Inc.

Completed

A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers

Healthy Volunteers | Anti-Bacterial Agents | Methicillin-Resistant Staphylococcus Aureus | Methicillin-Sensitive Staphylococcus Aureus Infection

Korea, Republic of
Intron Biotechnology, Inc.

Completed

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers

Healthy Volunteers | Anti-Bacterial Agents | Methicillin-Resistant Staphylococcus Aureus

Korea, Republic of
Nitric BioTherapeutics, Inc

Completed

A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis

Tinea Pedis

Canada, Saint Kitts and Nevis
Nitric BioTherapeutics, Inc

Completed

Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail

Onychomycosis

United States
Nitric BioTherapeutics, Inc

Terminated

Reduction of Bacteria in MRSA Positive Ulcers

Leg Ulcer | Pressure Ulcer

Canada
Invitrox
Reliant Pharmaceuticals

Completed

Lovaza's Effect on the Activation of Platelets (LEAP)

Cardiovascular Disease | Bleeding
Nitric BioTherapeutics, Inc

Terminated

Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers

Venous Ulcers

United States
Vitro Biopharma Inc.

Not yet recruiting

Safety & Efficacy of AlloRx SC® in PTHS Patients

Pitt Hopkins Syndrome
Nitto BioPharma, Inc.

Active, not recruiting

A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer

Colorectal Cancer | Pancreatic Cancer | Non-Small Cell Lung Cancer

United States
Nicox Ophthalmics, Inc.

Completed

Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis (Mississippi)

Blepharitis

United States
Nicox Ophthalmics, Inc.

Completed

Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Glaucoma, Open-Angle | Hypertension, Ocular

United States
Nipro Europe N.V.

Completed

In Vivo Evaluation of the Nipro Elisio™ Dialyzer

Chronic Kidney Disease

France
Nicox Ophthalmics, Inc.

Completed

Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis

Blepharitis

United States
Nicox Ophthalmics, Inc.

Completed

Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Mont Blanc)

Ocular Hypertension | Open Angle Glaucoma

United States
Nicox Ophthalmics, Inc.

Recruiting

Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution (Whistler)

Open Angle Glaucoma

United States
Nicox Ophthalmics, Inc.

Recruiting

MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali)

Ocular Hypertension | Open Angle Glaucoma

United States, China
Nitto Denko Corporation

Completed

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

Idiopathic Pulmonary Fibrosis

United States, Germany, Japan, United Kingdom
Nitto Denko Corporation

Completed

Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers

Influenza

Japan
University of Rochester
Litron Laboratories

Completed

Measuring Alterations of DNA in Human Blood

Neoplasms

United States
Boston Children's Hospital
Litron Laboratories

Completed

Defining Immunodeficiency in Heterotaxy Syndrome: Pilot Study Data

Heterotaxy Syndrome

United States
Arthritis Northwest PLLC
Epigenesys LLC

Unknown

Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease

Arthritis, Rheumatoid

United States
Loma Linda University
Nitric BioTherapeutics, Inc

Terminated

Topical Nitric Oxide Trial in Chronic Non-Healing Wounds

Chronic Ulcer of Lower Extremity

United States
Angle plc
MidLantic Urology, LLC

Terminated

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System (CHARTER)

Prostate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate Carcinoma

United States
NicOx Research Institute S.r.l.

Completed

Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)

Intermittent Claudication

Italy
Nicox Ophthalmics, Inc.
ORA, Inc.

Completed

A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution

Healthy Subjects

United States
Chris Miller
Mallinckrodt

Terminated

Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections

Respiratory Tract Infections | Corona Virus Infection

Canada
Synochi, LLC
LAC+USC Medical Center

Not yet recruiting

Prospective Placebo-controlled Study of Synochi Scar Spray

Burns Multiple

3

Subscribe